December 3rd 2024
Lonza’s new tailored offering leverages the company’s bi-layer capsule manufacturing technology.
June 11th 2024
Swiss CDMO CordenPharma and Spain-based Certest will collaborate on the development of ionizable lipids for LNP formulations.
May 21st 2024
The need for preclinical testing expertise is growing as molecular complexity increases.
May 4th 2024
A comparison between polysorbates and HPβCD determines the better stabilizer for biologics formulation.
September 13th 2023
Despite the successes that have already been achieved with emerging therapy development and manufacturing, companies are still facing numerous challenges.
WuXi XDC, Boostimmune Sign MOU
WuXi XDC will provide end-to-end services to support Boostimmune’s discovery of novel bioconjugates.
Moving Closer to Dynamic Drug Development
Hope is on the horizon as novel solutions and improvements aimed at benefitting the drug development process with the right framework are coming to the fore.
CROs Gaining a Competitive Edge
Shifting toward more technological solutions and ensuring a greater understanding of the workforce’s needs will give both CROs and sponsors a market advantage.
Adare Pharma Solutions Coordinating Quality with Veeva Vault Quality Suite
The Vault Quality Suite will help Adare simplify its quality operations across its sites in the United States, France, and Italy.
Societal CDMO Signs Multiple CDMO Service Agreements
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.
Advances in Drug Delivery and Areas for Improvement
While a variety of innovations have already impacted the drug delivery landscape, improving sustainability and having the ability to make smaller volumes of drug products still require work.
Deciding Where to Outsource in Biopharma Development and Manufacturing
Experts divulge where the industry is outsourcing most frequently, when companies should outsource more, and when performing tasks in-house might be best.
Balancing Internal Focus Against External Capabilities
Demand for outsourced services of technical R&D activities is increasing.
Fostering Orphan Drugs
CDMOs offer expertise and customization options for sponsors of orphan drugs.
Method Development in Demand
Experience is an invaluable asset for outsourcing partners, particularly as more challenging method development services are in demand.
Evolving Demands of Process Development Services
Shifting demands from industry innovators is leading to an increased need for flexible and agile outsourcing partners offering broad and integrated models.
Pharma Services Sector Poised for Continued Growth and Consolidation
The CRO market will see greater consolidation by both financial buyers looking to consolidate smaller players and larger CRO players wanting to expand into value-added specialty service areas.
SelectImmune and Lonza to Develop Immunotherapeutic Drug Candidate
The companies have entered into an agreement to develop processes for a novel immunotherapy protein.
Developing a Method for Success through Partnerships
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
COVID-19: Shoring Up the Drug Delivery Infrastructure
Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.
Seeking Early Answers to Formulation Questions
Contract service organizations can offer biopharma companies early insight into dangers that may hinder a drug’s later development.
Alcami Announces Biologics Enterprise
Alcami Biologics formed to meet market demands for biological drug development services.
Histo-Scientific Research Laboratories and Vet Path Services Merge
The merged companies will provide histopathology services in the research and pre-clinical therapeutics markets.
ADC Bio Secures Additional Equity Round Investment
ADC Biotechnology will invest downstream formulation, fill/finish capabilities, and Lock-Release conjugation technology.
Survey Predicts Drug Product Formulation Recognition and Increasing Budgets
Formulation issues cause significant drug project delays and project failures, according to a 2018 survey conducted by Informa Pharma Intelligence, Rentschler Biopharma, and LEUKOCARE.
Almac Invests in Next-Generation Sequencing Capabilities
The company says the new equipment will reduce sample turnaround times and increase variant detection quality and accuracy.
Vetter Launches Use-Centered Approach to Improve Injections
Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.
ADC Targets Fail Because of Aggregation Problems
ADC Bio experts warn of impending problems in the ADC pipeline with millions wasted in development costs.
Vetter Expands in Asia-Pacific
The company has officially opened a local brand office in South Korean to support its existing business in the region.
Ajinomoto Althea Adds High Potency Capabilities
Ajinomoto Althea opens manufacturing suites in new high potency and antibody drug conjugate commercial facility.
Catalent and Rutgers University to Study Pediatric Drug Challenges
Catalent Applied Drug Delivery Institute announced a partnership with Rutgers University to examine the challenges of pediatric drug formulation and delivery.
Vetter and Microdermics Form Pact to Develop Innovative Microneedle Drug Delivery Systems
Microdermics will focus on product development and clinical activities of new drug delivery methods, while Vetter’s primary role will be in the fill and finish aspect.
Nitto Avecia Expands Oligonucleotide Manufacturing Capacity
Avecia is adding drug substance capacity at its Milford, MA manufacturing site.
New Drug-Delivery Methods: From Concept to Patient
Challenging molecules and markets are driving the development of new solutions for drug delivery.
Agilent Plans Expansion of Oligo Manufacturing Capacity
Agilent Technologies announces plans to build a new oligo manufacturing facility in Colorado that will double current capacity.